2024MAY16 Public Opinion Surveys South Koreans and Their Neighbors 2024 Asan Public Opinion Survey Report
2024APR01 Past Events Asan Roundtable with the Delegation of the UN Institute for Training and … Tags : inter-Korean relations, support programs for developing countries, UN, UNITAR
2024FEB27 Issue Briefs Competing Great Power Coalitions [Issue Brief] The Asan Institute for Policy Studies Tags : “Global South”, APEC, ASEAN, coalition building, CPTPP, G7 Hiroshima Summit, MENA, NATO, Quad, RCEP, U.S.-China Strategic Competition, Ukraine—Russia, Xi Jinping
2023NOV15 Issue Briefs South Korea’s Quad Opportunity: Aligning Foreign Policy and Public Opinion By Peter K. Lee, Kang Chungku [Issue Brief] Peter K. Lee, Kang Chungku Tags : AUKUS, Australia, China, Climate, public opinion, Quad, South Korea, THAAD, US leadership
2023NOV15 Past Events Asan Roundtable with the Delegation of the Center for a New American Security … Tags : CNAS, Indo-Pacific, multilateral cooperation, regional strategies
2023APR26 Public Opinion Surveys South Koreans and Their Neighbors 2023 Asan Public Opinion Survey Report
2022AUG17 Issue Briefs Recommendations for a New Energy Policy By Choi Hyeonjung [Issue Brief Executive Summary] Choi Hyeonjung Tags : “nuclear phase-out”, CNGGC, COP26, Energy Policy, green energy, PCGG, Yoon Suk-yeol
2022MAY31 Publications South Korean Public Opinion on ROK-U.S. Bilateral Ties By J. James Kim, Kang Chungku, Ham Geon Hee [Asan Report] J. James Kim, Kang Chungku, Ham Geon Hee Tags : BMD, Korean Peninsula, President Biden, Quad, ROK - U.S, strong military, USFK, Yoon Suk-yeol
2021SEP24 Issue Briefs The 2021 Iranian Presidential Election and Its Aftermath By Jang Ji-Hyang, PARK Hyondo [Issue Brief Executive Summary] Jang Ji-Hyang, PARK Hyondo Tags : 2021 Iranian Presidential Election, Ebrahim Raisi, Electoral Authoritarianism, Iran's Hard-line President
2021JUL14 Issue Briefs The Perils of Openness? South Korea’s Quarantine Exemption for Chinese … By Lee Dong Gyu [Issue Brief Executive Summary] Lee Dong Gyu Tags : Chinese Vaccines, COVID-19, MFDS, Sinopharm, Sinovac, South Korea, US-China vaccine competition, WHO